Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Alyaa, Elkayal"'
Publikováno v:
Human Genomics, Vol 17, Iss 1, Pp 1-12 (2023)
Abstract Background HER2-positive breast cancer occurs in 15–20% of breast cancer patients and is characterized by poor prognosis. Trastuzumab is considered the key drug for treatment of HER2-positive breast cancer patients. It improves patient sur
Externí odkaz:
https://doaj.org/article/78b91233be6f48c0bc9b1205e671c285
Autor:
Mona Tahoun, Reham Fadl, Inas Ibrahim, Dalal El-Kaffash, Alyaa Elkayal, Marwa H. Saied, Reham Abdel Haleem, Amal Refeat, Eman Tayae
Publikováno v:
Molecular Medicine Reports. 24
Breast cancer (BC) is the most commonly diagnosed cancer worldwide and a major health concern in Egypt. There is a known association between pathogenic variants identified in breast cancer susceptibility gene (BRCA)1 and 2 and the risk of developing
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7684688cf64c0a8975c7b3ce67a64f64
https://doi.org/10.3892/mmr.2021.12317
https://doi.org/10.3892/mmr.2021.12317
Autor:
Marwa H, Saied, Dalal, Elkaffash, Reham, Fadl, Reham Abdel, Haleem, Amal, Refeat, Inas, Ibrahim, Mona, Tahoun, Alyaa, Elkayal, Eman, Tayae
Publikováno v:
Molecular medicine reports. 24(3)
Breast cancer (BC) is the most commonly diagnosed cancer worldwide and a major health concern in Egypt. There is a known association between pathogenic variants identified in breast cancer susceptibility gene (
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::357d1bb1c558ddb26359a3a2da53566f
https://pubmed.ncbi.nlm.nih.gov/34296289
https://pubmed.ncbi.nlm.nih.gov/34296289